ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,323Medicare Part D Prescriptions Filled, Including Refills

Rank: 273 out of 1844

$502K Total Retail Price of All Prescriptions

Rank: 353 out of 1844

440 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 440 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 440 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 379 334 1 7
OMEPRAZOLE 340 248 2 5
LEVOTHYROXINE SODIUM 306 253 3 1
ATENOLOL 269 223 4 17
LISINOPRIL 234 185 5 4
HYDROCODONE-ACETAMINOPHEN 219 125 S3 6 2
WARFARIN SODIUM 209 205 7 13
AMLODIPINE BESYLATE 196 191 8 6
SIMVASTATIN 183 144 9 3
GABAPENTIN 169 113 10 15
CITALOPRAM HBR 136 94 11 19
POTASSIUM CHLORIDE 132 112 12 16
SERTRALINE HCL 125 91 13 21
TRAMADOL HCL 123 106 14 18
TAMSULOSIN HCL 122 120 15 27
NAMENDA 120 107 16 33
POLYETHYLENE GLYCOL 3350 119 99 17 39
METFORMIN HCL 116 89 18 8
METOPROLOL SUCCINATE 102 71 19 14
METOPROLOL TARTRATE 102 88 19 11
ALLOPURINOL 97 73 21 29
MELOXICAM 96 82 22 28
PAROXETINE HCL 95 80 23 68
PANTOPRAZOLE SODIUM 91 67 24 32
HYDROCHLOROTHIAZIDE 86 66 25 9
CEPHALEXIN 83 55 26 56
NEXIUM 82 55 27 31
CARVEDILOL 77 68 28 22
CRESTOR 75 64 29 30
LANTUS 72 62 30 42
LOSARTAN POTASSIUM 71 51 31 24
CLOPIDOGREL 70 61 32 34
OXYCODONE HCL-ACETAMINOPHEN 66 0 S2 33 83
CELEBREX 62 19 34 91
SPIRONOLACTONE 62 46 34 60
AZITHROMYCIN 60 45 36 37
FAMOTIDINE 60 58 36 63
CYCLOBENZAPRINE HCL 59 33 R 38 53
NAPROXEN 58 31 39 87
BACLOFEN 58 13 39 119
PREDNISONE 58 51 39 40
FLUTICASONE PROPIONATE 57 42 42 50
AMITRIPTYLINE HCL 53 46 R 43 72
CEFUROXIME 53 46 43 184
ZOLPIDEM TARTRATE 52 17 45 23
IBUPROFEN 52 39 45 89
ESCITALOPRAM OXALATE 52 34 45 52
GLIMEPIRIDE 50 40 48 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.